Matthew W. Johnson, Ph.D

Clinical Advisor

Matthew W. Johnson, Ph.D., Professor at Johns Hopkins, is an expert on psychedelics, other drugs, and addiction. Working with psychedelics for 16 years, he has published approximately 50 scientific papers on psychedelics. Matt published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. He published the first research on psychedelic treatment of tobacco addiction in 2014, and the largest study of psilocybin in cancer distress in 2016. His 2018 psilocybin review recommended Schedule IV upon medical approval. He has guided >100 psychedelic sessions. Matt also conducts behavioral economic research on both addiction and sexual risk. He conducts research with most psychoactive drug classes, was 2018 President of the Psychopharmacology Division of the American Psychological Association, and is current President of the International Society for Research on Psychedelics. Interviewed by: 60 Minutes (CBS News), New York Times, Washington Post, Wall Street Journal, BBC, CNN, Fox Business News, NPR, and Michael Pollan.

JR Rahn Portrait

JR Rahn

Chief Executive Officer, Board Director, & Co-Founder

Dr. Miri Halperin Wernli Portrait

Dr. Miri Halperin Wernli

Executive President; Board Director; Chair of Technology Evaluation, Acquisition and Scientific Integrity Board Committee

Robert Barrow Portrait

Robert Barrow

Chief Development Officer

Carol Nast Portrait

Carol Nast

Chief Operating Officer

Donald Gehlert, PhD Portrait

Donald Gehlert, PhD

Chief Scientific Officer

Dave Guebert Portrait

Dave Guebert

Chief Financial Officer

Jeanne Bonelle Portrait

Jeanne Bonelle

EVP, Technical Operations

Shahera St. John Portrait

Shahera St. John

VP, Programs

Nico Forte Portrait

Nico Forte

Senior Director, Business Operations and Development

Carole Abel Portrait

Carole Abel

Senior Director Clinical Operations & Program Leader LSD

Madeline Feldman Portrait

Madeline Feldman

Director of Operations & Administration

Collin Gage Portrait

Collin Gage

Vice President of Corporate Development

Rachann McKnight Portrait

Rachann McKnight

Director, Business Process

Jon Polaha Portrait

Jon Polaha

Financial Analyst

Stanley D. Glick, PhD, MD Portrait

Stanley D. Glick, PhD, MD

Scientific Advisor

Natalie Wheeler, PhD Portrait

Natalie Wheeler, PhD

Medical Science Liaison with Dova Pharmaceuticals

Matthew W. Johnson, Ph.D Portrait

Matthew W. Johnson, Ph.D

Clinical Advisor

Kenneth Alper, MD Portrait

Kenneth Alper, MD

Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine

Dr. Peter Gasser Portrait

Dr. Peter Gasser

Clinical Advisor

Sarah McCallum, PhD Portrait

Sarah McCallum, PhD

Associate Professor of Neuroscience and Experimental Therapeutics (DNET) at Albany Medical College

John Rotrosen, MD Portrait

John Rotrosen, MD

Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry

Professor Dr. Matthias Liechti, PhD & M.D. Portrait

Professor Dr. Matthias Liechti, PhD & M.D.

Scientific Collaborator & Advisor

Dr. Kim Kuypers Portrait

Dr. Kim Kuypers

Scientific Collaborator & Advisor

Brigid Makes Portrait

Brigid Makes

Board Director, Chair of Audit Commitee, Member of Compensation, Nomination and Governance Committee

Perry Dellelce Portrait

Perry Dellelce

Chairman, Member of Audit and Compensation, Nomination and Governance Committees

Bruce Linton Portrait

Bruce Linton

Board Director, Chair of Compensation, Nomination and Governance Committee, Member of Audit Committee

Stephen L. Hurst, JD Portrait

Stephen L. Hurst, JD

Co-Founder and Board Director

Scott Freeman, MD Portrait

Scott Freeman, MD

Co-Founder & Clinical Advisor

Leonard Latchman Portrait

Leonard Latchman

Co-Founder